Ryanodine receptors (RyRs) are the Ca2+ release channels of sarcoplasmic reticulum that provide the majority of Ca2+ necessary to induce contraction of cardiac cells. In their intracellular environment, RyRs are regulated by a variety of cytosolic and luminal factors so that their output signal (Ca2+) induces finely graded cell contraction without igniting cellular processes that may lead to aberrant electrical activity (ventricular arrhythmias), the main cause of sudden death (SD). The importance of RyR dysfunction has been recently highlighted with the demonstration that point mutations in the cardiac RyR gene (hRYR2) are associated with Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT), an arrhythmogenic syndrome characterized by the development of adrenergically-mediated ventricular tachycardia in individuals with an apparently normal heart. The vast majority of CPVT mutations have been localized to three loci ("hot spots") of the RyR2 protein that affect different aspects of RyR function, however, the molecular mechanism that links a mutation in the RyR2 protein and the development of tachyarrhythmias remains incompletely understood. Our general hypothesis is that CPVT mutations cause multiple forms of RyR2 dysfunction, with the severity of the phenotype determined by the hierarchy of the affected domain in the control of Ca2+ release. To test this hypothesis, we will use single RyR2 channels, isolated ventricular myocytes and whole hearts from wild-type mice and knock-in mouse models of CPVT to: (1) determine whether distinct patterns of RyR2 dysfunction emerge from each of the three "hot spots" altered by CPVT mutations;(2) determine whether the presumably diverse RyR2 dysfunctions elicited by mutations in each of the three "hot spots" converge into a preponderant cellular mechanism of aberrant electrical activity;and (3) determine if the knock-in mouse models of CPVT develop similar phenotype and respond equally to ?-adrenergic stimulation and ?-blockers. We will use an array of state-of-the-art techniques including kinetic analysis of single channel activity by laser photolysis of "caged" Ca2+, high-speed Ca2+ imaging with laser scanning confocal microscopy, and recording of aberrant electrical activity in whole, beating hearts. The proposed experimental design will therefore combine molecular, cellular, and whole heart studies to elucidate the molecular mechanisms of RyR-initiated tachyarrhythmias with an unprecedented level of integrative physiology.

Public Health Relevance

Mutations in ion channels, the proteins that are responsible for generating electrical and calcium signals in the heart, can cause tachycardia and sudden death. This project studies how mutations in one important ion channel called the calcium release channel (ryanodine receptor) cause ventricular arrhythmia and sudden death. Successful completion of this study will allow us to rationalize a therapeutic approach for the optimal treatment of these disorders.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
7R01HL055438-16
Application #
8270571
Study Section
Special Emphasis Panel (ZRG1-CVS-N (02))
Program Officer
Krull, Holly
Project Start
1996-03-08
Project End
2014-04-30
Budget Start
2012-08-01
Budget End
2013-04-30
Support Year
16
Fiscal Year
2012
Total Cost
$388,750
Indirect Cost
$138,750
Name
University of Michigan Ann Arbor
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
073133571
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Escobar, Ariel L; Valdivia, Héctor H (2014) Cardiac alternans and ventricular fibrillation: a bad case of ryanodine receptors reneging on their duty. Circ Res 114:1369-71
Zhao, Yan-Ting; Valdivia, Héctor H (2014) Ca2+ nanosparks: shining light on the dyadic cleft but missing the intensity of its signal. Circ Res 114:396-8
Loaiza, Randall; Benkusky, Nancy A; Powers, Patricia P et al. (2013) Heterogeneity of ryanodine receptor dysfunction in a mouse model of catecholaminergic polymorphic ventricular tachycardia. Circ Res 112:298-308
Zhang, Hongyu; Makarewich, Catherine A; Kubo, Hajime et al. (2012) Hyperphosphorylation of the cardiac ryanodine receptor at serine 2808 is not involved in cardiac dysfunction after myocardial infarction. Circ Res 110:831-40
Ullrich, Nina D; Valdivia, Hector H; Niggli, Ernst (2012) PKA phosphorylation of cardiac ryanodine receptor modulates SR luminal Ca2+ sensitivity. J Mol Cell Cardiol 53:33-42
Altschafl, Beth A; Arvanitis, Demetrios A; Fuentes, Oscar et al. (2011) Dual role of junctin in the regulation of ryanodine receptors and calcium release in cardiac ventricular myocytes. J Physiol 589:6063-80
Wang, Honglan; Viatchenko-Karpinski, Serge; Sun, Junhui et al. (2010) Regulation of myocyte contraction via neuronal nitric oxide synthase: role of ryanodine receptor S-nitrosylation. J Physiol 588:2905-17
Touchberry, Chad D; Bales, Ian K; Stone, Jessica K et al. (2010) Phosphatidylinositol 3,5-bisphosphate (PI(3,5)P2) potentiates cardiac contractility via activation of the ryanodine receptor. J Biol Chem 285:40312-21
Gurrola, Georgina B; Capes, E Michelle; Zamudio, Fernando Z et al. (2010) Imperatoxin A, a Cell-Penetrating Peptide from Scorpion Venom, as a Probe of Ca-Release Channels/Ryanodine Receptors. Pharmaceuticals (Basel) 3:1093-1107
Romero-Suarez, Sandra; Shen, Jinhua; Brotto, Leticia et al. (2010) Muscle-specific inositide phosphatase (MIP/MTMR14) is reduced with age and its loss accelerates skeletal muscle aging process by altering calcium homeostasis. Aging (Albany NY) 2:504-13

Showing the most recent 10 out of 38 publications